77.70
+1.41%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Ashland
From its filings with the US Securities and Exchange Commission
Ashland is based in Wilmington, Delaware and is incorporated in Delaware. Its shares trade on NYSE under the ticker ASH. The SEC classifies its business as wholesale-chemicals & allied products. In the fiscal year to 30 September 2025, it reported revenue of $1.82bn and a net loss of $845.0m. At that date it held total assets of $4.61bn and shareholders' equity of $1.90bn. By business, Life sciences. brought in 35.1% of revenue, followed by Personal care. at 31.6% and Specialty additives. at 28.0%.
The Company serves customers in a wide range of consumer and industrial markets including, architectural coatings, construction, energy, food and beverage, personal care and pharmaceutical. With approximately 2,900 employees worldwide, Ashland serves customers in more than 100 countries.
Ashland’s reportable operating segments ("reportable segments") include: Life Sciences; Personal Care; Specialty Additives; and Intermediates. Unallocated and Other includes corporate governance activities and certain legacy matters.
Life Sciences is comprised of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films (formerly known as advanced materials) and fine chemicals. Pharmaceutical solutions include controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers and tablet binders. Nutrition solutions include thickeners, stabilizers, emulsifiers and additives for enhancing mouthfeel, controlling moisture migration, reducing oil uptake and binding structured foods. Customers include pharmaceutical, food, beverage, hospitals and radiologists manufacturers. The nutraceuticals business was sold in August 2024.
Quoted from its 10-K, filed 20 Nov 2025. Read the filing on SEC.gov ↗
Company facts
- Sector
- Materials
- Industry
- Chemicals
- Listed since
- 17 Mar 1980
- Employees
- 2,900
- Website
- ashland.com ↗
- Head office
- 8145 BLAZER DRIVE, WILMINGTON, DE, 19808
- Incorporated in
- DE
- Classification
- Wholesale-Chemicals & Allied Products
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. Guillermo NovoChairman of the Board, Chief Executive Officer, since 2019$7.9m
- Mr. William WhitakerChief Financial Officer, Senior Vice President$2.4m
- Ms. Eileen DruryChief Human Resources Officer, Senior Vice President
- Dr. Osama MusaSenior Vice President, Chief Technology Officer, since 2018$1.7m
- Ms. Robin LampkinSenior Vice President, General Counsel, Secretary
- Ms. Alessandra AssisSenior Vice President, General Manager - Life Sciences and Intermediates$2.1m
- Mr. Dago CaceresSenior Vice President, General Manager - Specialty Additives
- Mr. James MinicucciSenior Vice President, General Manager - Personal Care$1.4m
- Mr. Steven BishopIndependent Director$249,978
- Mr. Sanat ChattopadhyayIndependent Director$260,395
- Ms. Suzan HarrisonIndependent Director$268,300
- Dr. Ashish KulkarniIndependent Director$249,978
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 80
- Environment
- 76
- Social
- 99
- Governance
- 66
- Direct emissions (scope 1)
- 331,192 t
- Energy emissions (scope 2)
- 243,753 t
- Value chain emissions (scope 3)
- 705,365 t
- Women in the workforce
- 31%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Ashland Inc possesses several strengths that contribute to its success:
Weaknesses
- Despite its strengths, Ashland Inc faces certain weaknesses that need to be addressed:
Opportunities
- Ashland Inc can leverage the following opportunities to drive growth and expansion:
Threats
- Ashland Inc must be mindful of the following threats that could impact its business:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.